Benelux site
Pharmanovia enters in-licensing agreement with Axsome Therapeutics
Pharmanovia enters in-licensing agreement with Axsome Therapeutics to market and further develop...
More informationPharmanovia makes leadership hires in China
Pharmanovia, The Life Cycle Management Company, today confirmed that it has made two key appointments in China...
More informationPharmanovia bolsters Scientific Affairs team with new hires
Dr Claire Ives (Senior MSL Director) and Dr Fernando Osorio (MSL Director) will together head Pharmanovia’s influential Medical...
More informationPharmanovia enters exclusive licensing collaboration for Diazepam Buccal Film
For Trade and Medical Media ONLY PHARMANOVIA EXCLUSIVELY LICENCES RIGHTS FOR A NOVEL WAY OF TREATING...
More informationDKSH and Pharmanovia partner to respond to therapeutic needs in Southeast Asia
DKSH will support life cycle management company Pharmanovia in its mission to bring important medication to...
More informationTV Interview – SkyNews
London (UK), 20 June 2022 Ian King interviews Pharmavovia’s CEO, Dr James Burt on SkyNews
More informationPharmanovia expands its footprint in China with the acquisition of Rocaltrol® from Roche
Pharmanovia has acquired the commercial rights in China for Rocaltrol® (calcitriol) Roche. Pharmanovia obtained the...
More informationLife cycle management company Pharmanovia launches its inaugural sustainability report
The report celebrates the firm’s diversity and sets out ambitious environmental and sustainability targets London, UK...
More informationPharmanovia announces departure of Chief Corporate Development Officer Alastair Hay
LONDON – Alastair Hay is leaving his position as Chief Corporate Development Officer at the global...
More informationFor all media enquiries please contact: communications@pharmanovia.com